InChIKey	WGYPAJVJMXQXTR-ABNZCKJZSA-N
Canonical SMILES	C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	7.8
Source	BindingDB;ChEMBL

DrugBank ID	DB12128
Drug Name	Ulimorelin
CAS Number	842131-33-3
Groups	investigational
ATC Codes	nan
Description	Ulimorelin is a novel small molecule ghrelin agonist being developed by Tranzyme Pharma as a first-in-class treatment for both POI and diabetic gastroparesis, serious medical conditions in which motility of the GI tract is severely impaired.

---

Cross-references: BindingDB: 50359256 CHEMBL1963249 ChemSpider: 9701482 PubChem:11526696 PubChem:347828427 Wikipedia: Ulimorelin